CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

Children with no COVID-19 symptoms may shed virus for weeks

New research suggests that children can shed SARS-CoV-2, the virus that causes COVID-19, even if they never develop symptoms or for long after symptoms have cleared

Benchmark KFF Survey: Annual Family Premiums for Employer Coverage Rise 7% to Nearly $24,000 in 2023

Amid Changing Abortion Laws, 1-in-10 Large Firms Say Their Largest Plan Doesn’t Cover Legally Provided Abortions Under Any Circumstances

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

A New Program, Established by The Claims Conference and Funded by The German Government, Will Ensure Holocaust Survivors Globally Have the Means to Get To COVID-19 Vaccine Sites